Proceedings: Cultured lymphoblastoid lines as a model for leukaemia/lymphoma.

by Steel, C. M.
Published 1975

A systematic review of the effect of therapists’ internalised models of relationships on the quality of the therapeutic relationship

by Steel, C., Macdonald, J., Schröder, Thomas
Published 2018

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

by Thompson, A. M., Kerr, D. J., Steel, C. M.
Published 1991

Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies.

by Busby-Earle, R. M., Steel, C. M., Bird, C. C.
Published 1993

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.

by Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E. D., Steel, C. M., Elton, R. A.
Published 1998

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

by Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., Steel, C. M.
Published 1998

Mutations in p53 do not account for heritable breast cancer: a study in five affected families.

by Prosser, J., Elder, P. A., Condie, A., MacFadyen, I., Steel, C. M., Evans, H. J.
Published 1991

p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.

by Busby-Earle, R. M., Steel, C. M., Williams, A. R., Cohen, B., Bird, C. C.
Published 1994

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

by Devlin, J., Elder, P. A., Gabra, H., Steel, C. M., Knowles, M. A.
Published 1996

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

by Mackay, J., Elder, P. A., Porteous, D. J., Steel, C. M., Hawkins, R. A., Going, J. J., Chetty, U.
Published 1988

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up...

by Thompson, A. M., Crichton, D. N., Elton, R. A., Clay, M. F., Chetty, U., Steel, C. M.
Published 1998

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

by Prosser, J., Porter, D., Coles, C., Condie, A., Thompson, A. M., Chetty, U., Steel, C. M., Evans, H. J.
Published 1992

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

by Eccles, D. M., Brett, L., Lessells, A., Gruber, L., Lane, D., Steel, C. M., Leonard, R. C.
Published 1992

pS2 is an independent factor of good prognosis in primary breast cancer.

by Thompson, A. M., Hawkins, R. A., Elton, R. A., Steel, C. M., Chetty, U., Carter, D. C.
Published 1993

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

by Thompson, A. M., Morris, R. G., Wallace, M., Wyllie, A. H., Steel, C. M., Carter, D. C.
Published 1993

Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines.

by Bird, C. C., Waddell, A. W., Robertson, A. M., Currie, A. R., Steel, C. M., Evans, J.
Published 1975

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.

by Wyllie, A. H., Rose, K. A., Morris, R. G., Steel, C. M., Foster, E., Spandidos, D. A.
Published 1987

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

by Thompson, A. M., Steel, C. M., Chetty, U., Hawkins, R. A., Miller, W. R., Carter, D. C., Forrest, A. P., Evans, H. J.
Published 1990

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.

by Thompson, A. M., Steel, C. M., Foster, M. E., Kerr, D., Paterson, D., Deane, D., Hawkins, R. A., Carter, D. C., Evans, H. J.
Published 1990

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

by Gabra, H., Taylor, L., Cohen, B. B., Lessels, A., Eccles, D. M., Leonard, R. C., Smyth, J. F., Steel, C. M.
Published 1995